Global Leukocyte Surface Antigen CD47 Market Insights and Forecast to 2031

Report ID: 1564070 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Leukocyte Surface Antigen CD47 Product Introduction
    1.2 Market by Type
        1.2.1 Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 B-6H12
        1.2.3 ALX-148
        1.2.4 CC-90002
        1.2.5 PSTx-23
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Lymphoma
        1.3.3 Ovarian Cancer
        1.3.4 Ischemia Reperfusion Injury
        1.3.5 Kindney Transplant Rejection
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Leukocyte Surface Antigen CD47 Sales Estimates and Forecasts 2017-2028
    2.2 Global Leukocyte Surface Antigen CD47 Revenue Estimates and Forecasts 2017-2028
    2.3 Global Leukocyte Surface Antigen CD47 Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Leukocyte Surface Antigen CD47 Sales by Region
        2.4.1 Global Leukocyte Surface Antigen CD47 Sales by Region (2017-2022)
        2.4.2 Global Sales Leukocyte Surface Antigen CD47 by Region (2023-2028)
    2.5 Global Leukocyte Surface Antigen CD47 Revenue by Region
        2.5.1 Global Leukocyte Surface Antigen CD47 Revenue by Region (2017-2022)
        2.5.2 Global Leukocyte Surface Antigen CD47 Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Leukocyte Surface Antigen CD47 Sales by Manufacturers
        3.1.1 Global Top Leukocyte Surface Antigen CD47 Manufacturers by Sales (2017-2022)
        3.1.2 Global Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Leukocyte Surface Antigen CD47 in 2021
    3.2 Global Leukocyte Surface Antigen CD47 Revenue by Manufacturers
        3.2.1 Global Leukocyte Surface Antigen CD47 Revenue by Manufacturers (2017-2022)
        3.2.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Leukocyte Surface Antigen CD47 Revenue in 2021
    3.3 Global Leukocyte Surface Antigen CD47 Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Leukocyte Surface Antigen CD47 Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Leukocyte Surface Antigen CD47 Sales by Type
        4.1.1 Global Leukocyte Surface Antigen CD47 Historical Sales by Type (2017-2022)
        4.1.2 Global Leukocyte Surface Antigen CD47 Forecasted Sales by Type (2023-2028)
        4.1.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2028)
    4.2 Global Leukocyte Surface Antigen CD47 Revenue by Type
        4.2.1 Global Leukocyte Surface Antigen CD47 Historical Revenue by Type (2017-2022)
        4.2.2 Global Leukocyte Surface Antigen CD47 Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2028)
    4.3 Global Leukocyte Surface Antigen CD47 Price by Type
        4.3.1 Global Leukocyte Surface Antigen CD47 Price by Type (2017-2022)
        4.3.2 Global Leukocyte Surface Antigen CD47 Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Leukocyte Surface Antigen CD47 Sales by Application
        5.1.1 Global Leukocyte Surface Antigen CD47 Historical Sales by Application (2017-2022)
        5.1.2 Global Leukocyte Surface Antigen CD47 Forecasted Sales by Application (2023-2028)
        5.1.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2028)
    5.2 Global Leukocyte Surface Antigen CD47 Revenue by Application
        5.2.1 Global Leukocyte Surface Antigen CD47 Historical Revenue by Application (2017-2022)
        5.2.2 Global Leukocyte Surface Antigen CD47 Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2017-2028)
    5.3 Global Leukocyte Surface Antigen CD47 Price by Application
        5.3.1 Global Leukocyte Surface Antigen CD47 Price by Application (2017-2022)
        5.3.2 Global Leukocyte Surface Antigen CD47 Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Leukocyte Surface Antigen CD47 Market Size by Type
        6.1.1 North America Leukocyte Surface Antigen CD47 Sales by Type (2017-2028)
        6.1.2 North America Leukocyte Surface Antigen CD47 Revenue by Type (2017-2028)
    6.2 North America Leukocyte Surface Antigen CD47 Market Size by Application
        6.2.1 North America Leukocyte Surface Antigen CD47 Sales by Application (2017-2028)
        6.2.2 North America Leukocyte Surface Antigen CD47 Revenue by Application (2017-2028)
    6.3 North America Leukocyte Surface Antigen CD47 Market Size by Country
        6.3.1 North America Leukocyte Surface Antigen CD47 Sales by Country (2017-2028)
        6.3.2 North America Leukocyte Surface Antigen CD47 Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Leukocyte Surface Antigen CD47 Market Size by Type
        7.1.1 Europe Leukocyte Surface Antigen CD47 Sales by Type (2017-2028)
        7.1.2 Europe Leukocyte Surface Antigen CD47 Revenue by Type (2017-2028)
    7.2 Europe Leukocyte Surface Antigen CD47 Market Size by Application
        7.2.1 Europe Leukocyte Surface Antigen CD47 Sales by Application (2017-2028)
        7.2.2 Europe Leukocyte Surface Antigen CD47 Revenue by Application (2017-2028)
    7.3 Europe Leukocyte Surface Antigen CD47 Market Size by Country
        7.3.1 Europe Leukocyte Surface Antigen CD47 Sales by Country (2017-2028)
        7.3.2 Europe Leukocyte Surface Antigen CD47 Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Leukocyte Surface Antigen CD47 Market Size by Type
        8.1.1 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Type (2017-2028)
        8.1.2 Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Type (2017-2028)
    8.2 Asia Pacific Leukocyte Surface Antigen CD47 Market Size by Application
        8.2.1 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Application (2017-2028)
        8.2.2 Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Application (2017-2028)
    8.3 Asia Pacific Leukocyte Surface Antigen CD47 Market Size by Region
        8.3.1 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region (2017-2028)
        8.3.2 Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Leukocyte Surface Antigen CD47 Market Size by Type
        9.1.1 Latin America Leukocyte Surface Antigen CD47 Sales by Type (2017-2028)
        9.1.2 Latin America Leukocyte Surface Antigen CD47 Revenue by Type (2017-2028)
    9.2 Latin America Leukocyte Surface Antigen CD47 Market Size by Application
        9.2.1 Latin America Leukocyte Surface Antigen CD47 Sales by Application (2017-2028)
        9.2.2 Latin America Leukocyte Surface Antigen CD47 Revenue by Application (2017-2028)
    9.3 Latin America Leukocyte Surface Antigen CD47 Market Size by Country
        9.3.1 Latin America Leukocyte Surface Antigen CD47 Sales by Country (2017-2028)
        9.3.2 Latin America Leukocyte Surface Antigen CD47 Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Type
        10.1.1 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Type (2017-2028)
    10.2 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Application
        10.2.1 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Application (2017-2028)
    10.3 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Country
        10.3.1 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Aurigene Discovery Technologies Ltd
        11.1.1 Aurigene Discovery Technologies Ltd Corporation Information
        11.1.2 Aurigene Discovery Technologies Ltd Overview
        11.1.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Aurigene Discovery Technologies Ltd Recent Developments
    11.2 Celgene Corp
        11.2.1 Celgene Corp Corporation Information
        11.2.2 Celgene Corp Overview
        11.2.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Celgene Corp Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Celgene Corp Recent Developments
    11.3 Forty Seven Inc
        11.3.1 Forty Seven Inc Corporation Information
        11.3.2 Forty Seven Inc Overview
        11.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Forty Seven Inc Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Forty Seven Inc Recent Developments
    11.4 Surface Oncology Inc
        11.4.1 Surface Oncology Inc Corporation Information
        11.4.2 Surface Oncology Inc Overview
        11.4.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Surface Oncology Inc Recent Developments
    11.5 Trillium Therapeutics Inc
        11.5.1 Trillium Therapeutics Inc Corporation Information
        11.5.2 Trillium Therapeutics Inc Overview
        11.5.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Trillium Therapeutics Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Leukocyte Surface Antigen CD47 Industry Chain Analysis
    12.2 Leukocyte Surface Antigen CD47 Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Leukocyte Surface Antigen CD47 Production Mode & Process
    12.4 Leukocyte Surface Antigen CD47 Sales and Marketing
        12.4.1 Leukocyte Surface Antigen CD47 Sales Channels
        12.4.2 Leukocyte Surface Antigen CD47 Distributors
    12.5 Leukocyte Surface Antigen CD47 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Leukocyte Surface Antigen CD47 Industry Trends
    13.2 Leukocyte Surface Antigen CD47 Market Drivers
    13.3 Leukocyte Surface Antigen CD47 Market Challenges
    13.4 Leukocyte Surface Antigen CD47 Market Restraints
14 Key Findings in The Global Leukocyte Surface Antigen CD47 Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of B-6H12
    Table 3. Major Manufacturers of ALX-148
    Table 4. Major Manufacturers of CC-90002
    Table 5. Major Manufacturers of PSTx-23
    Table 6. Major Manufacturers of Others
    Table 7. Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Leukocyte Surface Antigen CD47 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Leukocyte Surface Antigen CD47 Sales by Region (2017-2022) & (K Pcs)
    Table 10. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2017-2022)
    Table 11. Global Leukocyte Surface Antigen CD47 Sales by Region (2023-2028) & (K Pcs)
    Table 12. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2023-2028)
    Table 13. Global Leukocyte Surface Antigen CD47 Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2017-2022)
    Table 15. Global Leukocyte Surface Antigen CD47 Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2023-2028)
    Table 17. Global Leukocyte Surface Antigen CD47 Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 18. Global Leukocyte Surface Antigen CD47 Sales Share by Manufacturers (2017-2022)
    Table 19. Global Leukocyte Surface Antigen CD47 Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Leukocyte Surface Antigen CD47 Revenue Share by Manufacturers (2017-2022)
    Table 21. Leukocyte Surface Antigen CD47 Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 22. Global Leukocyte Surface Antigen CD47 Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Leukocyte Surface Antigen CD47 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukocyte Surface Antigen CD47 as of 2021)
    Table 24. Leukocyte Surface Antigen CD47 Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Leukocyte Surface Antigen CD47 Product Offered
    Table 26. Date of Manufacturers Enter into Leukocyte Surface Antigen CD47 Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
    Table 29. Global Leukocyte Surface Antigen CD47 Sales by Type (2023-2028) & (K Pcs)
    Table 30. Global Leukocyte Surface Antigen CD47 Sales Share by Type (2017-2022)
    Table 31. Global Leukocyte Surface Antigen CD47 Sales Share by Type (2023-2028)
    Table 32. Global Leukocyte Surface Antigen CD47 Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Leukocyte Surface Antigen CD47 Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Leukocyte Surface Antigen CD47 Revenue Share by Type (2017-2022)
    Table 35. Global Leukocyte Surface Antigen CD47 Revenue Share by Type (2023-2028)
    Table 36. Leukocyte Surface Antigen CD47 Price by Type (2017-2022) & (USD/Pcs)
    Table 37. Global Leukocyte Surface Antigen CD47 Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 38. Global Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
    Table 39. Global Leukocyte Surface Antigen CD47 Sales by Application (2023-2028) & (K Pcs)
    Table 40. Global Leukocyte Surface Antigen CD47 Sales Share by Application (2017-2022)
    Table 41. Global Leukocyte Surface Antigen CD47 Sales Share by Application (2023-2028)
    Table 42. Global Leukocyte Surface Antigen CD47 Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Leukocyte Surface Antigen CD47 Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Leukocyte Surface Antigen CD47 Revenue Share by Application (2017-2022)
    Table 45. Global Leukocyte Surface Antigen CD47 Revenue Share by Application (2023-2028)
    Table 46. Leukocyte Surface Antigen CD47 Price by Application (2017-2022) & (USD/Pcs)
    Table 47. Global Leukocyte Surface Antigen CD47 Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 48. North America Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
    Table 49. North America Leukocyte Surface Antigen CD47 Sales by Type (2023-2028) & (K Pcs)
    Table 50. North America Leukocyte Surface Antigen CD47 Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Leukocyte Surface Antigen CD47 Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
    Table 53. North America Leukocyte Surface Antigen CD47 Sales by Application (2023-2028) & (K Pcs)
    Table 54. North America Leukocyte Surface Antigen CD47 Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Leukocyte Surface Antigen CD47 Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Leukocyte Surface Antigen CD47 Sales by Country (2017-2022) & (K Pcs)
    Table 57. North America Leukocyte Surface Antigen CD47 Sales by Country (2023-2028) & (K Pcs)
    Table 58. North America Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Leukocyte Surface Antigen CD47 Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
    Table 61. Europe Leukocyte Surface Antigen CD47 Sales by Type (2023-2028) & (K Pcs)
    Table 62. Europe Leukocyte Surface Antigen CD47 Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Leukocyte Surface Antigen CD47 Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
    Table 65. Europe Leukocyte Surface Antigen CD47 Sales by Application (2023-2028) & (K Pcs)
    Table 66. Europe Leukocyte Surface Antigen CD47 Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Leukocyte Surface Antigen CD47 Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Leukocyte Surface Antigen CD47 Sales by Country (2017-2022) & (K Pcs)
    Table 69. Europe Leukocyte Surface Antigen CD47 Sales by Country (2023-2028) & (K Pcs)
    Table 70. Europe Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Leukocyte Surface Antigen CD47 Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
    Table 73. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Type (2023-2028) & (K Pcs)
    Table 74. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
    Table 77. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Application (2023-2028) & (K Pcs)
    Table 78. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region (2017-2022) & (K Pcs)
    Table 81. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region (2023-2028) & (K Pcs)
    Table 82. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
    Table 85. Latin America Leukocyte Surface Antigen CD47 Sales by Type (2023-2028) & (K Pcs)
    Table 86. Latin America Leukocyte Surface Antigen CD47 Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Leukocyte Surface Antigen CD47 Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
    Table 89. Latin America Leukocyte Surface Antigen CD47 Sales by Application (2023-2028) & (K Pcs)
    Table 90. Latin America Leukocyte Surface Antigen CD47 Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Leukocyte Surface Antigen CD47 Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Leukocyte Surface Antigen CD47 Sales by Country (2017-2022) & (K Pcs)
    Table 93. Latin America Leukocyte Surface Antigen CD47 Sales by Country (2023-2028) & (K Pcs)
    Table 94. Latin America Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Leukocyte Surface Antigen CD47 Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
    Table 97. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Type (2023-2028) & (K Pcs)
    Table 98. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
    Table 101. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Application (2023-2028) & (K Pcs)
    Table 102. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2017-2022) & (K Pcs)
    Table 105. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2023-2028) & (K Pcs)
    Table 106. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Aurigene Discovery Technologies Ltd Corporation Information
    Table 109. Aurigene Discovery Technologies Ltd Description and Major Businesses
    Table 110. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 111. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Aurigene Discovery Technologies Ltd Recent Developments
    Table 113. Celgene Corp Corporation Information
    Table 114. Celgene Corp Description and Major Businesses
    Table 115. Celgene Corp Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 116. Celgene Corp Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Celgene Corp Recent Developments
    Table 118. Forty Seven Inc Corporation Information
    Table 119. Forty Seven Inc Description and Major Businesses
    Table 120. Forty Seven Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 121. Forty Seven Inc Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Forty Seven Inc Recent Developments
    Table 123. Surface Oncology Inc Corporation Information
    Table 124. Surface Oncology Inc Description and Major Businesses
    Table 125. Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 126. Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Surface Oncology Inc Recent Developments
    Table 128. Trillium Therapeutics Inc Corporation Information
    Table 129. Trillium Therapeutics Inc Description and Major Businesses
    Table 130. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 131. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Trillium Therapeutics Inc Recent Developments
    Table 133. Key Raw Materials Lists
    Table 134. Raw Materials Key Suppliers Lists
    Table 135. Leukocyte Surface Antigen CD47 Distributors List
    Table 136. Leukocyte Surface Antigen CD47 Customers List
    Table 137. Leukocyte Surface Antigen CD47 Market Trends
    Table 138. Leukocyte Surface Antigen CD47 Market Drivers
    Table 139. Leukocyte Surface Antigen CD47 Market Challenges
    Table 140. Leukocyte Surface Antigen CD47 Market Restraints
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Leukocyte Surface Antigen CD47 Product Picture
    Figure 3. Global Leukocyte Surface Antigen CD47 Market Share by Type in 2021 & 2028
    Figure 3. B-6H12 Product Picture
    Figure 4. ALX-148 Product Picture
    Figure 5. CC-90002 Product Picture
    Figure 6. PSTx-23 Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Leukocyte Surface Antigen CD47 Market Share by Application in 2021 & 2028
    Figure 9. Lymphoma
    Figure 10. Ovarian Cancer
    Figure 11. Ischemia Reperfusion Injury
    Figure 12. Kindney Transplant Rejection
    Figure 13. Others
    Figure 14. Leukocyte Surface Antigen CD47 Report Years Considered
    Figure 15. Global Leukocyte Surface Antigen CD47 Sales 2017-2028 (K Pcs)
    Figure 16. Global Leukocyte Surface Antigen CD47 Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Leukocyte Surface Antigen CD47 Revenue 2017-2028 (US$ Million)
    Figure 18. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2017-2022)
    Figure 20. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2023-2028)
    Figure 21. North America Leukocyte Surface Antigen CD47 Sales YoY (2017-2028) & (K Pcs)
    Figure 22. North America Leukocyte Surface Antigen CD47 Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Leukocyte Surface Antigen CD47 Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Europe Leukocyte Surface Antigen CD47 Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Leukocyte Surface Antigen CD47 Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Asia-Pacific Leukocyte Surface Antigen CD47 Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Leukocyte Surface Antigen CD47 Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Latin America Leukocyte Surface Antigen CD47 Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Leukocyte Surface Antigen CD47 Sales YoY (2017-2028) & (K Pcs)
    Figure 30. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Leukocyte Surface Antigen CD47 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Leukocyte Surface Antigen CD47 in the World: Market Share by Leukocyte Surface Antigen CD47 Revenue in 2021
    Figure 33. Global Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2028)
    Figure 35. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2028)
    Figure 36. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2028)
    Figure 37. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2017-2028)
    Figure 38. North America Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2028)
    Figure 39. North America Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2028)
    Figure 40. North America Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2028)
    Figure 41. North America Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2017-2028)
    Figure 42. North America Leukocyte Surface Antigen CD47 Sales Share by Country (2017-2028)
    Figure 43. North America Leukocyte Surface Antigen CD47 Revenue Share by Country (2017-2028)
    Figure 44. U.S. Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2028)
    Figure 47. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2028)
    Figure 49. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Leukocyte Surface Antigen CD47 Sales Share by Country (2017-2028)
    Figure 51. Europe Leukocyte Surface Antigen CD47 Revenue Share by Country (2017-2028)
    Figure 52. Germany Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 53. France Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Leukocyte Surface Antigen CD47 Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Leukocyte Surface Antigen CD47 Revenue Share by Region (2017-2028)
    Figure 63. China Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 66. India Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Leukocyte Surface Antigen CD47 Sales Share by Country (2017-2028)
    Figure 78. Latin America Leukocyte Surface Antigen CD47 Revenue Share by Country (2017-2028)
    Figure 79. Mexico Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Share by Country (2017-2028)
    Figure 88. Turkey Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 90. UAE Leukocyte Surface Antigen CD47 Revenue (2017-2028) & (US$ Million)
    Figure 91. Leukocyte Surface Antigen CD47 Value Chain
    Figure 92. Leukocyte Surface Antigen CD47 Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc
Frequently Asked Questions
Leukocyte Surface Antigen CD47 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Leukocyte Surface Antigen CD47 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Leukocyte Surface Antigen CD47 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Beta-Carotene

Beta-Carotene market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Calcium glycinate

Calcium glycinate market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More